
P/E Ratio: Price to Earnings - Most used valuation metric
Analyzing Investment Quality
Processing 9 key metrics...
Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format
Standalone annual data is not available for this symbol.
Try switching to Consolidated view.
Loading shareholding data...
| Insider Name | Transaction Date | Filing Date | Total Shares | Change | Price | Action |
|---|---|---|---|---|---|---|
Raymond Paul Roach | 06 Jan 2025 | 06 Jan 2025 | 8,308 | 4,154 | ₹321 | BUY |
James William Ringer | 30 Jan 2025 | 30 Jan 2025 | 6,230 | 3,115 | - | BUY |
Faiz Arif Nagariya | 14 May 2025 | 15 May 2025 | 4,808 | 545 | ₹727 | BUY |
Purnima Ashwin Desai | 14 May 2025 | 15 May 2025 | 2.31 Cr | 89.79 L | ₹730.88 | SELL |
Standard pivot points - most widely used
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹980.20 | +₹48.05 | +5.15% |
| R3 | ₹961.25 | +₹29.10 | +3.12% |
| R2 | ₹952.45 | +₹20.30 | +2.18% |
| R1 | ₹942.30 | +₹10.15 | +1.09% |
| PIVOT | ₹933.50 | 1.35 | 0.14% |
| CURRENT | ₹932.15 | - | - |
| S1 | ₹885.45 | -₹46.70 | -5.01% |
| S2 | ₹904.40 | -₹27.75 | -2.98% |
| S3 | ₹914.55 | -₹17.60 | -1.89% |
| S4 | ₹923.35 | -₹8.80 | -0.94% |
is trading CPR, indicating
CPR is
Day's range: ~
Trading Inside opening range
| Company Name |
|---|
Aarti Pharmalabs Ltd |
Alivus Life Sciences Ltd |
Alembic Pharmaceuticals Ltd |
Blue Jet Healthcare Ltd |
Caplin Point Laboratories Ltd |
Cohance Lifesciences Ltd |
Concord Biotech Ltd |
FDC Ltd |
Granules India Ltd |
Jubilant Pharmova Ltd |
Marksans Pharma Ltd |
Natco Pharma Ltd |
Procter & Gamble Health Ltd |
Sanofi India Ltd |
Sanofi Consumer Healthcare India Ltd |
Shilpa Medicare Ltd |
Strides Pharma Science Ltd |
Sun Pharmaceutical Industries Ltd |
Supriya Lifescience Ltd |

Aether Industries Limited is an Indian chemical company specializing in the production and sale of advanced intermediates and specialty chemicals both domestically and internationally. Their product portfolio is diverse, catering to a range of industrial sectors. The company's manufacturing capabilities are geared towards creating high-value, specialized chemical compounds rather than mass-produced commodities.
Aether's product line includes a variety of complex organic molecules, each with specific applications in different industries. These include 4-(2-Methoxyethyl) phenol, 3-Methoxy-2-Methylbenzoyl Chloride, Thiophene-2-ethanol, Ortho Tolyl Benzo Nitrile / 4'-Methyl-2-Cyanobiphynyl, N-Octyl-D-glucamine/1- deoxy-1-(Octylamino)-D-Glucitol, 1-2-(2Hydroxyethoxy) Ethyl Piperazine, Delta-Valerolactone, and bifenthrin alcohol. The complexity of these chemicals indicates a focus on high-value, niche markets.
The company's customer base spans several key industries. Pharmaceutical companies utilize Aether's products in drug synthesis. Agrochemical firms incorporate them into pesticide and herbicide formulations. The material science sector benefits from Aether's offerings in developing new materials with specialized properties. Furthermore, Aether's chemicals find application in high-performance photography, various additives, and even the oil and gas industry, highlighting the broad applicability and versatility of their production.
Beyond direct product sales, Aether also provides contract research and manufacturing services (CRAMS), and contract/exclusive manufacturing services. This aspect of their business allows them to offer customized chemical synthesis solutions to clients, further enhancing their market reach and positioning them as a flexible and responsive partner for various industrial needs. This flexibility and breadth of services differentiate Aether in a competitive chemical market.
Founded in 2013 and headquartered in Surat, India, Aether Industries Limited has established itself as a key player in the specialized chemical sector. Their focus on advanced intermediates and specialty chemicals, coupled with their CRAMS capabilities, positions them for continued growth and expansion in both domestic and international markets.
Plot No.8203, Road No. 82, GIDC Industrial Estate,Sachin
Surat
GUJARAT
IN
Tel: 912616603000
Website:https://aether.co.in/
Group: Pharmaceuticals, Biotechnology & Life Sciences
Sector: Health Care
Industry: Pharmaceuticals
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 970
IPO Date: 03/06/2022
Mr. Kamalvijay Tulsian
Non-Executive Chairman of the Board
Mr. Faiz Nagariya
Chief Financial Officer
Dr. James Ringer
Chief Technology Officer
Mr. Chitrarth Parghi
Compliance Officer, Company Secretary
Mr. Ashwin Desai
Managing Director, Executive Director
Dr. Aman Desai
Whole Time Director
Ms. Purnima Desai
Whole Time Director
Mr. Rohan Desai
Whole Time Director
Dr. Norbert Fluggen
Business Development Leader (Europe)
Mr. Raymond Roach
Business Development Leader (Americas)
Ms. Ishita Manjrekar
Non-Executive Director
Mr. Rajkumar Borana
Non-Executive Independent Director
Get answers to the most common questions about Aether Industries Ltd stock price, fundamentals, financial metrics, and investment analysis